AN2 Therapeutics, Inc.

Healthcare

NASDAQ:ANTX · NASDAQ Global Select

Market Cap $129.89M Beta -0.98 P/E (TTM) -4.7

$4.74 +6.52%

+$0.29 today

52W Low $1.00High $6.91

Vol 0.19M · Avg 0.30M

EPS (TTM)-$1.01

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+342.99%

Period High

$5.46

Period Low

$1.03

Latest

$4.74

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Q32 Bio Inc.

NASDAQ:QTTB

$161.49M

Verrica Pharmaceuticals Inc.

NASDAQ:VRCA

$61.03M

SAB Biotherapeutics, Inc.

SABS

$31.83M

Boundless Bio, Inc.

BOLD

$31.67M

iBio, Inc.

IBIO

$26.68M

Pluri Inc.

PLUR

$20.41M

Plus Therapeutics, Inc.

PSTV

$12.12M

Intensity Therapeutics, Inc.

INTS

$6.83M

NextCure, Inc.

NXTC

$5.56M

Iterum Therapeutics plc

ITRM

$1.60M

What is the latest ANTX filing?

The latest filing shown is 8-K dated Jun 9, 2026.

How many recent filings does ANTX have?

Intrinsic Alpha currently shows 20 recent filings for ANTX.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.